RPS outlines plans to shape future of pharmacy in Wales


Share post:

The Royal Pharmaceutical Society (RPS) has published Pharmacy: Delivering a Healthier Wales that outlines a plan focusing on what can be achieved by end of 2025.

The society has urged people to share their views by responding to the consultation on four key themes which were already set out in Pharmacy: Delivering a Healthier Wales –enhancing patient experience; developing the pharmacy workforce; seamless pharmaceutical care; and harnessing innovation and technology.

“We want to hear from as many of you as possible. It is important that the aims for pharmacy over the next three years are right. So please take a look at the draft 2025 goals, the proposed activity and measures and complete our consultation response form by 11 September,” said RPS.

“We have been proud to continue to manage this important ambition for Wales, working on behalf of the Welsh Pharmaceutical Committee and with colleagues from all over Wales. Over 300 of you have already contributed to our face to face and virtual engagement sessions we held over the past three months and we thank you for your valuable input.

“We are confident the draft goals are ambitious, patient focused and will harness the contribution of the entire pharmacy team in all care settings.  We now need to hear your views on how the 2025 goals meet your expectations for the future development of pharmacy in Wales.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...